Joerger, M. and Templeton, A. and Köberle, D. and Engler, H. and Riesen, W. F. and Thürlimann, B.. (2011) Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer chemotherapy and pharmacology, Vol. 67, H. 5. pp. 1137-1144.
Full text not available from this repository.
Official URL: http://edoc.unibas.ch/dok/A6004701
Downloads: Statistics Overview
Abstract
There is an urgent need for individualized treatment of malignant bone disease (MBD), as the clinical benefit from bone-targeted therapies is moderate. We assessed the predictive value of the bone formation marker procollagen type I N-propeptide (PINP) for skeletal morbidity in patients with MBD receiving pamidronate.
| Faculties and Departments: | 03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Onkologie 03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Onkologie |
|---|---|
| UniBasel Contributors: | Thürlimann, Beat |
| Item Type: | Article, refereed |
| Article Subtype: | Research Article |
| Publisher: | Springer |
| ISSN: | 0344-5704 |
| Note: | Publication type according to Uni Basel Research Database: Journal article |
| Last Modified: | 27 Mar 2014 13:13 |
| Deposited On: | 27 Mar 2014 13:13 |
Repository Staff Only: item control page